APO RESEARCH · REPORT
1-Butyl-3-methylimidazolium Bromide
1-Butyl-3-methylimidazolium Bromide is a heterocyclic chemical substance identified by its named ring and substituent structure.

Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-3-methylimidazolium Bromide. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 1-Butyl-3-methylimidazolium Bromide?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1-Butyl-3-methylimidazolium Bromide. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Industry Growth & Trends
Global 1-Butyl-3-methylimidazolium Bromide Industry Growth and Trends Forecast to 2032
Market perspective
The global 1-Butyl-3-methylimidazolium Bromide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 1-Butyl-3-methylimidazolium Bromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 1-Butyl-3-methylimidazolium Bromide include Shandong DYCK Biotech, Jinkai Chemical, Henan Lihua Pharmaceutical and Changzhou Chongkai Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global 1-Butyl-3-methylimidazolium Bromide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The 1-Butyl-3-methylimidazolium Bromide market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 1-Butyl-3-methylimidazolium Bromide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 1-Butyl-3-methylimidazolium Bromide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global 1-Butyl-3-methylimidazolium Bromide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
1-Butyl-3-methylimidazolium Bromide Market by Company
Shandong DYCK Biotech
Jinkai Chemical
Henan Lihua Pharmaceutical
Changzhou Chongkai Chemical
1-Butyl-3-methylimidazolium Bromide Segment by Type
≥99.0% Purity
<99.0% Purity
1-Butyl-3-methylimidazolium Bromide Segment by Application
Plasticizer
Other
1-Butyl-3-methylimidazolium Bromide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1-Butyl-3-methylimidazolium Bromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 1-Butyl-3-methylimidazolium Bromide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1-Butyl-3-methylimidazolium Bromide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 1-Butyl-3-methylimidazolium Bromide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of 1-Butyl-3-methylimidazolium Bromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ≥99.0% Purity
- <99.0% Purity
Applications
- Plasticizer
- Other
Companies covered
- Shandong DYCK Biotech
- Jinkai Chemical
- Henan Lihua Pharmaceutical
- Changzhou Chongkai Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 1-Butyl-3-methylimidazolium Bromide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global 1-Butyl-3-methylimidazolium Bromide Sales Estimates and Forecasts (2021-2032)
- 1.3 1-Butyl-3-methylimidazolium Bromide Market by Type
- 1.3.1 ≥99.0% Purity
- 1.3.2 <99.0% Purity
- 1.4 Global 1-Butyl-3-methylimidazolium Bromide Market Size by Type
- 1.4.1 Global 1-Butyl-3-methylimidazolium Bromide Market Size Overview by Type (2021-2032)
- 1.4.2 Global 1-Butyl-3-methylimidazolium Bromide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global 1-Butyl-3-methylimidazolium Bromide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 1-Butyl-3-methylimidazolium Bromide Industry Trends
- 2.2 1-Butyl-3-methylimidazolium Bromide Industry Drivers
- 2.3 1-Butyl-3-methylimidazolium Bromide Industry Opportunities and Challenges
- 2.4 1-Butyl-3-methylimidazolium Bromide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by 1-Butyl-3-methylimidazolium Bromide Revenue (2021-2026)
- 3.2 Global Top Players by 1-Butyl-3-methylimidazolium Bromide Sales (2021-2026)
- 3.3 Global Top Players by 1-Butyl-3-methylimidazolium Bromide Price (2021-2026)
- 3.4 Global 1-Butyl-3-methylimidazolium Bromide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 1-Butyl-3-methylimidazolium Bromide Major Company Production Sites & Headquarters
- 3.6 Global 1-Butyl-3-methylimidazolium Bromide Company, Product Type & Application
- 3.7 Global 1-Butyl-3-methylimidazolium Bromide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 1-Butyl-3-methylimidazolium Bromide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 1-Butyl-3-methylimidazolium Bromide Players Market Share by Revenue in 2025
- 3.8.3 2025 1-Butyl-3-methylimidazolium Bromide Tier 1, Tier 2, and Tier 3
4 1-Butyl-3-methylimidazolium Bromide Regional Status and Outlook
- 4.1 Global 1-Butyl-3-methylimidazolium Bromide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global 1-Butyl-3-methylimidazolium Bromide Historic Market Size by Region
- 4.2.1 Global 1-Butyl-3-methylimidazolium Bromide Sales in Volume by Region (2021-2026)
- 4.2.2 Global 1-Butyl-3-methylimidazolium Bromide Sales in Value by Region (2021-2026)
- 4.2.3 Global 1-Butyl-3-methylimidazolium Bromide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global 1-Butyl-3-methylimidazolium Bromide Forecasted Market Size by Region
- 4.3.1 Global 1-Butyl-3-methylimidazolium Bromide Sales in Volume by Region (2027-2032)
- 4.3.2 Global 1-Butyl-3-methylimidazolium Bromide Sales in Value by Region (2027-2032)
- 4.3.3 Global 1-Butyl-3-methylimidazolium Bromide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 1-Butyl-3-methylimidazolium Bromide by Application
- 5.1 1-Butyl-3-methylimidazolium Bromide Market by Application
- 5.1.1 Plasticizer
- 5.1.2 Other
- 5.2 Global 1-Butyl-3-methylimidazolium Bromide Market Size by Application
- 5.2.1 Global 1-Butyl-3-methylimidazolium Bromide Market Size Overview by Application (2021-2032)
- 5.2.2 Global 1-Butyl-3-methylimidazolium Bromide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global 1-Butyl-3-methylimidazolium Bromide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Shandong DYCK Biotech
- 6.1.1 Shandong DYCK Biotech Company Information
- 6.1.2 Shandong DYCK Biotech Business Overview
- 6.1.3 Shandong DYCK Biotech 1-Butyl-3-methylimidazolium Bromide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Shandong DYCK Biotech 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.1.5 Shandong DYCK Biotech Recent Developments
- 6.2 Jinkai Chemical
- 6.2.1 Jinkai Chemical Company Information
- 6.2.2 Jinkai Chemical Business Overview
- 6.2.3 Jinkai Chemical 1-Butyl-3-methylimidazolium Bromide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Jinkai Chemical 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.2.5 Jinkai Chemical Recent Developments
- 6.3 Henan Lihua Pharmaceutical
- 6.3.1 Henan Lihua Pharmaceutical Company Information
- 6.3.2 Henan Lihua Pharmaceutical Business Overview
- 6.3.3 Henan Lihua Pharmaceutical 1-Butyl-3-methylimidazolium Bromide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Henan Lihua Pharmaceutical 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.3.5 Henan Lihua Pharmaceutical Recent Developments
- 6.4 Changzhou Chongkai Chemical
- 6.4.1 Changzhou Chongkai Chemical Company Information
- 6.4.2 Changzhou Chongkai Chemical Business Overview
- 6.4.3 Changzhou Chongkai Chemical 1-Butyl-3-methylimidazolium Bromide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Changzhou Chongkai Chemical 1-Butyl-3-methylimidazolium Bromide Product Portfolio
- 6.4.5 Changzhou Chongkai Chemical Recent Developments
7 North America by Country
- 7.1 North America 1-Butyl-3-methylimidazolium Bromide Sales by Country
- 7.1.1 North America 1-Butyl-3-methylimidazolium Bromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America 1-Butyl-3-methylimidazolium Bromide Sales by Country (2021-2026)
- 7.1.3 North America 1-Butyl-3-methylimidazolium Bromide Sales Forecast by Country (2027-2032)
- 7.2 North America 1-Butyl-3-methylimidazolium Bromide Market Size by Country
- 7.2.1 North America 1-Butyl-3-methylimidazolium Bromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America 1-Butyl-3-methylimidazolium Bromide Market Size by Country (2021-2026)
- 7.2.3 North America 1-Butyl-3-methylimidazolium Bromide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe 1-Butyl-3-methylimidazolium Bromide Sales by Country
- 8.1.1 Europe 1-Butyl-3-methylimidazolium Bromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe 1-Butyl-3-methylimidazolium Bromide Sales by Country (2021-2026)
- 8.1.3 Europe 1-Butyl-3-methylimidazolium Bromide Sales Forecast by Country (2027-2032)
- 8.2 Europe 1-Butyl-3-methylimidazolium Bromide Market Size by Country
- 8.2.1 Europe 1-Butyl-3-methylimidazolium Bromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe 1-Butyl-3-methylimidazolium Bromide Market Size by Country (2021-2026)
- 8.2.3 Europe 1-Butyl-3-methylimidazolium Bromide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Sales by Country
- 9.1.1 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Market Size by Country
- 9.2.1 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific 1-Butyl-3-methylimidazolium Bromide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America 1-Butyl-3-methylimidazolium Bromide Sales by Country
- 10.1.1 South America 1-Butyl-3-methylimidazolium Bromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America 1-Butyl-3-methylimidazolium Bromide Sales by Country (2021-2026)
- 10.1.3 South America 1-Butyl-3-methylimidazolium Bromide Sales Forecast by Country (2027-2032)
- 10.2 South America 1-Butyl-3-methylimidazolium Bromide Market Size by Country
- 10.2.1 South America 1-Butyl-3-methylimidazolium Bromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America 1-Butyl-3-methylimidazolium Bromide Market Size by Country (2021-2026)
- 10.2.3 South America 1-Butyl-3-methylimidazolium Bromide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Sales by Country
- 11.1.1 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Market Size by Country
- 11.2.1 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa 1-Butyl-3-methylimidazolium Bromide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 1-Butyl-3-methylimidazolium Bromide Value Chain Analysis
- 12.1.1 1-Butyl-3-methylimidazolium Bromide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 1-Butyl-3-methylimidazolium Bromide Production Mode & Process
- 12.2 1-Butyl-3-methylimidazolium Bromide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 1-Butyl-3-methylimidazolium Bromide Distributors
- 12.2.3 1-Butyl-3-methylimidazolium Bromide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst